(MedPage Today) — Note that some links may require registration or subscription.
After patient deaths from interstitial lung disease in a lung cancer trial testing the antibody-drug conjugate ifinatamab deruxtecan, the FDA placed a partial hold…
Source link : https://www.medpagetoday.com/hematologyoncology/lungcancer/119101
Author :
Publish date : 2025-12-19 14:32:00
Copyright for syndicated content belongs to the linked Source.
